These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23341901)

  • 1. Utility of NT-proBNP for identifying LV failure in patients with acute exacerbation of chronic bronchitis.
    Wang QP; Cao XZ; Wang XD; Gu J; Wen LM; Mao LM; Shan PN; Tang AG
    PLoS One; 2013; 8(1):e52553. PubMed ID: 23341901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
    Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of NT-proBNP as a rule-out test for left ventricular dysfunction in very old people with limiting dyspnoea: the Newcastle 85+ Study.
    Collerton J; Kingston A; Yousaf F; Davies K; Kenny A; Neely D; Martin-Ruiz C; MacGowan G; Robinson L; Kirkwood TB; Keavney B
    BMC Cardiovasc Disord; 2014 Sep; 14():128. PubMed ID: 25257704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal-pro-B-type natriuretic peptide (NT-proBNP): reference range for Chinese apparently healthy people and clinical performance in Chinese elderly patients with heart failure.
    Shi X; Xu G; Xia T; Song Y; Lin Q
    Clin Chim Acta; 2005 Oct; 360(1-2):122-7. PubMed ID: 16002063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of plasma NT-proBNP levels for excluding cardiac abnormalities in the very elderly.
    Vaes B; Delgado V; Bax J; Degryse J; Westendorp RG; Gussekloo J
    BMC Geriatr; 2010 Nov; 10():85. PubMed ID: 21070664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Personal experience with determination of NT-proBNP in clinical practice].
    Stejskal D; Oral I; Lacnák B; Juráková R; Horalík D; Adamovská S; Prosková J; Hrabovská I; Ozanová G
    Vnitr Lek; 2003 Feb; 49(2):121-6. PubMed ID: 12728579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.
    Abroug F; Ouanes-Besbes L; Nciri N; Sellami N; Addad F; Hamda KB; Amor AB; Najjar MF; Knani J
    Am J Respir Crit Care Med; 2006 Nov; 174(9):990-6. PubMed ID: 16840745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.
    Januzzi JL; Rehman SU; Mohammed AA; Bhardwaj A; Barajas L; Barajas J; Kim HN; Baggish AL; Weiner RB; Chen-Tournoux A; Marshall JE; Moore SA; Carlson WD; Lewis GD; Shin J; Sullivan D; Parks K; Wang TJ; Gregory SA; Uthamalingam S; Semigran MJ
    J Am Coll Cardiol; 2011 Oct; 58(18):1881-9. PubMed ID: 22018299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients.
    Iwasaki M; Joki N; Tanaka Y; Ikeda N; Hayashi T; Kubo S; Asakawa T; Takahashi Y; Hirahata K; Imamura Y; Hase H
    Nephrology (Carlton); 2013 Jul; 18(7):497-504. PubMed ID: 23574011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
    Andrijevic I; Milutinov S; Lozanov Crvenkovic Z; Matijasevic J; Andrijevic A; Kovacevic T; Bokan D; Zaric B
    Lung; 2018 Oct; 196(5):583-590. PubMed ID: 29951921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential diagnostic value of serum NT-proBNP in hospitalized patients of heart failure with pneumonia.
    Yang S; Li L; Cao J; Yu H; Xu H
    J Clin Lab Anal; 2015 Jan; 29(1):37-42. PubMed ID: 24687945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.
    Felker GM; Whellan D; Kraus WE; Clare R; Zannad F; Donahue M; Adams K; McKelvie R; Piña IL; O'Connor CM;
    Am Heart J; 2009 Oct; 158(4 Suppl):S37-44. PubMed ID: 19782787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.